Intraarterial Therapies for the Management of Hepatocellular Carcinoma

Tushar Garg; Apurva Shrigiriwar; Peiman Habibollahi; Mircea Cristescu; Robert P. Liddell; Julius Chapiro; Peter Inglis; Juan C. Camacho; Nariman Nezami

doi:10.3390/cancers14143351

Intraarterial Therapies for the Management of Hepatocellular Carcinoma

Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Image-guided locoregional therapies play a crucial role in the management of patients with hepatocellular carcinoma (HCC). Transarterial therapies consist of a group of catheter-based treatments where embolic agents are delivered directly into the tumor via their supplying arteries. Some of the transarterial therapies available include bland embolization (TAE), transarterial chemoembolization (TACE), drug-eluting beads–transarterial chemoembolization (DEB–TACE), selective internal radioembolization therapy (SIRT), and hepatic artery infusion (HAI). This article provides a review of pre-procedural, intra-procedural, and post-procedural aspects of each therapy, along with a review of the literature. Newer embolotherapy options and future directions are also briefly discussed.

Original language	English (US)
Article number	3351
Journal	Cancers
Volume	14
Issue number	14
DOIs	https://doi.org/10.3390/cancers14143351
State	Published - Jul 2022

Keywords

bland embolization
drug-eluting beads–transarterial chemoembolization
hepatic artery infusion
hepatocellular carcinoma
selective internal radioembolization therapy
transarterial chemoembolization

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3390/cancers14143351

Cite this

@article{626b973273fb4c61b412258adbd9f6b4,

title = "Intraarterial Therapies for the Management of Hepatocellular Carcinoma",

abstract = "Image-guided locoregional therapies play a crucial role in the management of patients with hepatocellular carcinoma (HCC). Transarterial therapies consist of a group of catheter-based treatments where embolic agents are delivered directly into the tumor via their supplying arteries. Some of the transarterial therapies available include bland embolization (TAE), transarterial chemoembolization (TACE), drug-eluting beads–transarterial chemoembolization (DEB–TACE), selective internal radioembolization therapy (SIRT), and hepatic artery infusion (HAI). This article provides a review of pre-procedural, intra-procedural, and post-procedural aspects of each therapy, along with a review of the literature. Newer embolotherapy options and future directions are also briefly discussed.",

keywords = "bland embolization, drug-eluting beads–transarterial chemoembolization, hepatic artery infusion, hepatocellular carcinoma, selective internal radioembolization therapy, transarterial chemoembolization",

author = "Tushar Garg and Apurva Shrigiriwar and Peiman Habibollahi and Mircea Cristescu and Liddell, {Robert P.} and Julius Chapiro and Peter Inglis and Camacho, {Juan C.} and Nariman Nezami",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = jul,

doi = "10.3390/cancers14143351",

language = "English (US)",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "14",

}

TY - JOUR

T1 - Intraarterial Therapies for the Management of Hepatocellular Carcinoma

AU - Garg, Tushar

AU - Shrigiriwar, Apurva

AU - Habibollahi, Peiman

AU - Cristescu, Mircea

AU - Liddell, Robert P.

AU - Chapiro, Julius

AU - Inglis, Peter

AU - Camacho, Juan C.

AU - Nezami, Nariman

PY - 2022/7

Y1 - 2022/7

N2 - Image-guided locoregional therapies play a crucial role in the management of patients with hepatocellular carcinoma (HCC). Transarterial therapies consist of a group of catheter-based treatments where embolic agents are delivered directly into the tumor via their supplying arteries. Some of the transarterial therapies available include bland embolization (TAE), transarterial chemoembolization (TACE), drug-eluting beads–transarterial chemoembolization (DEB–TACE), selective internal radioembolization therapy (SIRT), and hepatic artery infusion (HAI). This article provides a review of pre-procedural, intra-procedural, and post-procedural aspects of each therapy, along with a review of the literature. Newer embolotherapy options and future directions are also briefly discussed.

AB - Image-guided locoregional therapies play a crucial role in the management of patients with hepatocellular carcinoma (HCC). Transarterial therapies consist of a group of catheter-based treatments where embolic agents are delivered directly into the tumor via their supplying arteries. Some of the transarterial therapies available include bland embolization (TAE), transarterial chemoembolization (TACE), drug-eluting beads–transarterial chemoembolization (DEB–TACE), selective internal radioembolization therapy (SIRT), and hepatic artery infusion (HAI). This article provides a review of pre-procedural, intra-procedural, and post-procedural aspects of each therapy, along with a review of the literature. Newer embolotherapy options and future directions are also briefly discussed.

KW - bland embolization

KW - drug-eluting beads–transarterial chemoembolization

KW - hepatic artery infusion

KW - hepatocellular carcinoma

KW - selective internal radioembolization therapy

KW - transarterial chemoembolization

UR - http://www.scopus.com/inward/record.url?scp=85136381185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136381185&partnerID=8YFLogxK

U2 - 10.3390/cancers14143351

DO - 10.3390/cancers14143351

M3 - Review article

C2 - 35884412

AN - SCOPUS:85136381185

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 14

M1 - 3351

ER -

Intraarterial Therapies for the Management of Hepatocellular Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this